Should a patient with an estimated right ventricular systolic pressure of 46 mmHg undergo a right‑heart catheterization?

Right Heart Catheterization for RVSP 46 mmHg

A patient with an estimated RVSP of 46 mmHg should undergo right heart catheterization if there are clinical symptoms (dyspnea, exercise intolerance, signs of right heart failure) or if the finding will change management, as echocardiographic estimates correlate poorly with invasive measurements and this pressure level suggests clinically significant pulmonary hypertension that requires definitive hemodynamic characterization. 1, 2

Why This Matters

An RVSP of 46 mmHg is well above the concerning threshold. The evidence shows that:

• Mortality risk increases substantially above ePASP 30 mmHg, with 5-year mortality of 28.9% for ePASP 30-32 mmHg—2.5-fold higher than those with ePASP <22 mmHg 3
• Your patient's RVSP of 46 mmHg places them at even higher risk
• Right heart catheterization remains the gold standard for diagnosing pulmonary hypertension, which is defined hemodynamically as mean PAP >20 mmHg 1, 2, 4

The Problem with Echocardiography Alone

Echocardiographic estimates are notoriously unreliable:

• Correlation between echo-estimated PASP and catheterization-measured values is poor (r=0.49-0.80 across studies) 5, 6, 4
• The Bland-Altman mean difference can be 7.75 mmHg 6
• 10% of patients with invasively confirmed PH have no measurable tricuspid regurgitation jet, meaning echo would completely miss the diagnosis 4
• In heart transplant candidates, echo estimates "should not be exclusively relied upon" for clinical decisions 5

When to Proceed with Catheterization

Proceed with RHC if any of the following apply:

1. Symptomatic patients with dyspnea, exercise intolerance, or signs of right heart failure 7
2. Echo-estimated PA pressure >40 mmHg (your patient qualifies) 6
3. When the diagnosis will change management—particularly if considering:
   • Pulmonary vasodilator therapy
   • Heart transplant evaluation 5
   • Transcatheter valve interventions 8
4. Predominant right heart failure symptoms 7
5. Impaired right ventricular function on imaging 7

Critical Information RHC Provides That Echo Cannot

Right heart catheterization will definitively determine:

• Actual mean PAP (not just estimated systolic pressure)
• Pulmonary vascular resistance—distinguishes reactive vs. passive PH
• Pulmonary artery wedge pressure—differentiates pre-capillary from post-capillary PH (Group 1 vs. Group 2), which fundamentally changes treatment 1, 8
• Cardiac output—assesses hemodynamic significance
• Presence of intracardiac shunts—can be missed on echo 8

Common Pitfall to Avoid

Do not rely solely on echo to exclude significant PH or to guide treatment decisions. The case report 8 illustrates how RHC revealed partial anomalous pulmonary venous return with combined pre- and post-capillary PH in a patient being considered for tricuspid valve repair—findings that completely changed management and made the planned intervention inappropriate.

The Bottom Line Algorithm

For your patient with RVSP 46 mmHg:

1. Is the patient symptomatic? → If YES, proceed with RHC
2. Will the diagnosis change management? → If YES, proceed with RHC
3. Are there signs of RV dysfunction on echo? → If YES, proceed with RHC
4. Is this an asymptomatic incidental finding with normal RV function? → Consider RHC if patient has risk factors for PH (connective tissue disease, prior PE, liver disease, HIV, drugs/toxins) or if clinical suspicion remains high

Given that mortality risk is already elevated at this pressure level 3 and echo correlation is poor 5, 6, the threshold for proceeding with RHC should be low in the presence of any clinical concern.